HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dior's Three-Year Beauty Plan Expected To Double U.S. Business - CEO Brady

This article was originally published in The Rose Sheet

Executive Summary

As part of an aggressive plan to more than double Christian Dior's U.S. beauty business by 2003, President and CEO Robert Brady is ramping up its national advertising support and in-store sampling efforts and lighting a fire under its product introduction schedule. Christian Dior is awaiting final approval of the plan from parent company LVMH.

You may also be interested in...



Christian Dior J'Adore Women's Scent To Debut In February

J'Adore, the latest addition to Christian Dior's fragrance stable, captures the "essence of the 21st century woman," according to the LVMH subsidiary. J'Adore will bow in February exclusively at Saks Fifth Avenue doors nationwide and Christian Dior boutiques.

Christian Dior J'Adore Women's Scent To Debut In February

J'Adore, the latest addition to Christian Dior's fragrance stable, captures the "essence of the 21st century woman," according to the LVMH subsidiary. J'Adore will bow in February exclusively at Saks Fifth Avenue doors nationwide and Christian Dior boutiques.

Christian Dior Phenomen-A Double Retinol Complex Kicks Off Fall Launch Plan

Christian Dior Phenomen-A antiwrinkle treatment is formulated with a "double retinol" complex, which appears to "plump up" wrinkles from beneath the skin for a "more resilient" looking complexion Christian Dior claims. Phenomen-A is among two major product launches for Dior this fall.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006881

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel